STAT
JULY 24, 2023
The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in 2027.
Pharmafile
JANUARY 25, 2023
Lilly’s expansion is set to include the addition of further parenteral filling, device assembly and packaging capacity in order to meet the growing demand for the company’s incretin-based diabetes treatments and medications. The facility is expected to become operational in 2027 and will create over 100 new jobs for manufacturing personnel.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 28, 2023
EMA prepares for winter antibiotic shortages PFAS restriction in pharmaceutical manufacturing In its current form, the procedure currently underway could lead to a ban on all PFASs by 2027, with very limited derogations, EFPIA acknowledged. PFAS are used throughout the production process of medicines.
The Checkup by Singlecare
JANUARY 18, 2024
in 2027 and other countries in 2025, when a generic version may be approved. intrauterine device of brand-name Skyla See latest prices Heather (norethindrone) $46 per 1 package of 28, 0.35 mg tablets $5 per 1 package of 28, 0.35 mg tablets $5 per 1 package of 28, 0.35 Is Nexplanon covered by insurance?
pharmaphorum
FEBRUARY 3, 2022
reaching £915 billion by 2027. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9%
pharmaphorum
JANUARY 18, 2022
million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Primary Packaging material designers. Secondary packagers. Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. The global pre-filled syringes market was valued at $1139.6
Viseven
JUNE 12, 2023
from 2022 to 2027. Main Potential of Pharma in the Asia-Pacific Region What role does the APAC region play in transforming today’s worldwide pharma market? This role is significant because the pharma market in APAC is increasing. According to one forecast, researchers anticipate that APAC pharma will grow 4.2% And it makes sense.
Expert insights. Personalized for you.
93 
Let's personalize your content